Agilent Technologies, Inc. $A Stock: Robeco Institutional Asset Management B.V. Raises Stake

Robeco Institutional Asset Management B.V. lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 89.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 558,144 shares of the medical research company’s stock after purchasing an additional 263,871 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.20% of Agilent Technologies worth $96,174,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of A. Bank of Nova Scotia bought a new position in Agilent Technologies in the second quarter valued at $58,539,000. Dudley & Shanley Inc. lifted its position in Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock worth $9,232,000 after buying an additional 14,300 shares during the last quarter. BIP Wealth LLC bought a new stake in Agilent Technologies in the 2nd quarter worth approximately $834,000. Sivia Capital Partners LLC bought a new stake in Agilent Technologies in the 2nd quarter worth approximately $1,818,000. Finally, Capricorn Fund Managers Ltd purchased a new stake in Agilent Technologies in the first quarter worth approximately $8,161,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares in the company, valued at $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link.

Agilent Technologies Stock Up 2.8%

Shares of Agilent Technologies stock opened at $177.93 on Thursday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $178.21. The company has a market cap of $50.16 billion, a P/E ratio of 35.03, a PEG ratio of 2.63 and a beta of 1.21. The company’s fifty day simple moving average is $160.50 and its two-hundred day simple moving average is $138.97.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same period last year, the company posted $1.37 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be paid a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is presently 20.08%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on A. Citigroup upped their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Weiss Ratings upgraded Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Royal Bank Of Canada upped their price target on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Barclays upped their price target on Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Finally, JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $173.65.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.